These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19000325)

  • 1. Immunization against Clostridium perfringens cells elicits protection against Clostridium tetani in mouse model: identification of cross-reactive proteins using proteomic methodologies.
    Alam SI; Bansod S; Singh L
    BMC Microbiol; 2008 Nov; 8():194. PubMed ID: 19000325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for
    Ding G; Bai J; Feng B; Wang L; Qiao X; Zhou H; Jiang Y; Cui W; Tang L; Li Y; Xu Y
    Virulence; 2019 Dec; 10(1):754-767. PubMed ID: 31429624
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential proteomic analysis of Clostridium perfringens ATCC13124; identification of dominant, surface and structure associated proteins.
    Alam SI; Bansod S; Kumar RB; Sengupta N; Singh L
    BMC Microbiol; 2009 Aug; 9():162. PubMed ID: 19664283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clostridium perfringens beta toxin DNA prime-protein boost elicits enhanced protective immune response in mice.
    Solanki AK; Bhatia B; Kaushik H; Deshmukh SK; Dixit A; Garg LC
    Appl Microbiol Biotechnol; 2017 Jul; 101(14):5699-5708. PubMed ID: 28523396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoproteins from Clostridium perfringens and their protective efficacy in mouse model.
    Dwivedi P; Alam SI; Kumar O; Kumar RB
    Infect Genet Evol; 2015 Aug; 34():434-43. PubMed ID: 26027922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The genome sequence of Clostridium tetani, the causative agent of tetanus disease.
    Bruggemann H; Baumer S; Fricke WF; Wiezer A; Liesegang H; Decker I; Herzberg C; Martinez-Arias R; Merkl R; Henne A; Gottschalk G
    Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1316-21. PubMed ID: 12552129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genomic analysis of a neurotoxigenic Clostridium species using partial genome sequence: Phylogenetic analysis of a few conserved proteins involved in cellular processes and metabolism.
    Alam SI; Dixit A; Tomar A; Singh L
    Anaerobe; 2010 Apr; 16(2):147-54. PubMed ID: 19527791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of protection afforded by a Clostridium perfringens alpha-toxoid against heterologous clostridial phospholipases C.
    Neeson BN; Clark GC; Atkins HS; Lingard B; Titball RW
    Microb Pathog; 2007 Oct; 43(4):161-5. PubMed ID: 17604945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A recombinant carboxy-terminal domain of alpha-toxin protects mice against Clostridium perfringens.
    Nagahama M; Oda M; Kobayashi K; Ochi S; Takagishi T; Shibutani M; Sakurai J
    Microbiol Immunol; 2013 May; 57(5):340-5. PubMed ID: 23668605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
    Uppalapati SR; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation schedule for the prevention of infectious necrotic enteritis caused by Clostridium perfringens type C in piglets.
    Ripley PH; Gush AF
    Vet Rec; 1983 Feb; 112(9):201-2. PubMed ID: 6301137
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization with an alphatoxin variant 121A/91-R212H protects mice against Clostridium perfringens alphatoxin.
    Schoepe H; Neubauer A; Schlapp T; Wieler LH; Baljer G
    Anaerobe; 2006 Feb; 12(1):44-8. PubMed ID: 16701610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An international survey of clostridial sera and vaccines.
    Davidson I
    Dev Biol Stand; 1976; 32():3-14. PubMed ID: 187508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of broiler chickens against Clostridium perfringens-induced necrotic enteritis using purified recombinant immunogenic proteins.
    Jiang Y; Kulkarni RR; Parreira VR; Prescott JF
    Avian Dis; 2009 Sep; 53(3):409-15. PubMed ID: 19848081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
    Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
    Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
    Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
    Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative proteomic analysis of extracellular proteins of Clostridium perfringens type A and type C strains.
    Sengupta N; Alam SI; Kumar B; Kumar RB; Gautam V; Kumar S; Singh L
    Infect Immun; 2010 Sep; 78(9):3957-68. PubMed ID: 20605988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on the antigenic structure of anatoxins of Clostridium perfringens, Cl. oedematiens, Cl. septicum and Cl. tetani by determining their fixation properties].
    Kalinichenko NF
    Mikrobiol Zh; 1966; 28(4):75-7. PubMed ID: 4297189
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection against Staphylococcus aureus and tetanus infections by a combined vaccine containing SasA and TeNT‑Hc in mice.
    Yang Y; Yu R; Yang X; Liu S; Fang T; Song X; Hou L; Yu C; Xu J; Fu L; Yi S; Chen W
    Mol Med Rep; 2017 Apr; 15(4):2369-2373. PubMed ID: 28259925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and immunological characterization of an inactivated canine Clostridium perfringens type A vaccine.
    Xing J; Ji X; Sun Y; Zhu L; Jiang Q; Guo X; Liu J
    Lett Appl Microbiol; 2019 Nov; 69(5):385-390. PubMed ID: 31529707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.